T he validity of a diagnostic test or monitoring technology is based on both accuracy and reproducibility. Accuracy is defined as the degree to which a given test provides measurements in agreement with a known reference standard. Reproducibility of a diagnostic test is defined as the ability to achieve the same result when the test is repeated under similar circumstances. Understanding the accuracy and reproducibility of a diagnostic test forms the foundation for determining whether a change in the measure is due to normal physiology or test reproducibility, or due to clinically significant changes as a result of the underlying disease or therapeutic intervention.
Impedance cardiography (ICG) is a noninvasive hemodynamic diagnostic and monitoring technology.
1 Previous generations of ICG devices yielded inconsistent results compared with invasive hemodynamic methodology, 2, 3 but the most recent generation of ICG has shown improved accuracy in a broad range of patient populations. 4 -8 In recent years, ICG has established a role in the outpatient management of patients with hypertension, heart failure, and other chronic diseases. 9, 10 The use of ICG in therapeutic decision making regarding such patients is primarily based on its ability to identify the presence or absence of hemodynamic abnormalities and therefore target hemodynamically active medications to alleviate symptoms, lower patient risk, or better reach a clinical goal such as control of blood pressure (BP) levels.
Establishing the reproducibility of ICG parameters in stable outpatients is important to determine whether a change in any ICG parameter is due to either a significant change in disease status or to an effect of therapy, or whether it is a result of normal physiologic or technologic variation. The aim of this study was to evaluate the intraand inter-day reproducibility of ICG parameters in a stable population with coronary artery disease (CAD).
Methods

Patients
A convenience sample of clinically stable CAD patients participating in an outpatient cardiac rehabilitation program who met inclusion criteria were enrolled in the study. Clinical stability was defined as: 1) the absence of clinically significant changes in symptoms or physical signs as determined by examination by the attending physician, and 2) no changes in medical therapy during the interval between the inter-day studies. Patients were required to be Ͼ48 inches but Ͻ90 inches in height, and Ͼ67 but Ͻ341 pounds in weight. All patients provided written informed consent.
Exclusion Criteria
Patients were excluded from the study if they had one or more of the following: a minute ventilation pacemaker, severe aortic valve disease, clinical instability, medication, or clinical changes as determined by an examining physician or reported by the patient. 
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changes in thoracic impedance related to the change in the size of the thoracic aorta and reflecting stroke volume.
Data Collection
A nurse trained in the application of ICG obtained all hemodynamic measurements. Height, weight, gender, and BP obtained via a Dinamap 1846 SX Vital Signs monitor (Critikon, Tampa, FL) were entered into the ICG device. Measurements were obtained with the patient in the supine position at rest for 12 min during each of two monitoring sessions, 1 week apart. Blood pressure measurements were entered into the ICG device at four and nine minutes each session. The ICG data were recorded at 5 and 10 minutes of each session. Measurements at the specified time periods were based upon 30 beats of averaged data. After 1 week, measurements were obtained using the same method as the previous week. Any changes in pacemaker settings, medications, or exercise status were recorded.
Data and Statistical Analysis
Patient data files were transferred from the ICG device and converted to an Excel (Microsoft, Redmond, WA) format. Intra-day comparison was between the 5-and 10-min parameter values. Inter-day comparison was between the average of the 5-and 10-min parameter values on week 1 and week 2. Descriptive statistics were performed to obtain the group mean, standard deviation, and 95% confidence interval for parameter measurements at each time period. The paired t test was used to determine significant differences (P Ͻ .05). Intra-day and inter-day correlation of each parameter was calculated by the Pearson method. The absolute value of the difference between parameter measurements was calculated and was reported for each 
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group as the mean absolute difference and mean absolute percent difference. The mean absolute percent difference was calculated by comparing the absolute difference to the parameter measurement at the prior time (5-min values for intra-day, week 1 values for inter-day) and reported as a percentage. Mean, standard deviation, and 95% confidence interval for the absolute and absolute percent differences are reported.
Results
Patient Characteristics
A total of 96 patients, 55 (57%) female and 41 (43%) male, enrolled in the study and met the inclusion criteria for week 1 intra-day reproducibility measurements. A total of 71 patients, 40 (56%) female and 31 (44%) male, met the inclusion criterion of clinical stability for inter-day reproducibility measurements. Of the 25 patients who were excluded from inter-day measurements, 13 had a change in their exercise status, four had a change in both exercise and medication, four had a change in medication only, three did not return for their second visit, and one had a change in pacemaker setting.
Intra-Day Reproducibility
The reproducibility of the 10-min values compared with the 5-min values for mean arterial pressure (MAP), heart rate (HR), stroke index (SI), cardiac index (CI), systemic vascular resistance index (SVRI), thoracic fluid content (TFC), velocity index (VI), and systolic time ratio (STR) are summarized in Tables 1 and 2 and plotted in Figs. 2-9. All parameters exhibited a strong intra-day correlation. Mean arterial pressure had the lowest intra-day correlation (r ϭ 0.85), whereas the correlation for the ICG parameters ranged from 0.91 for STR to 0.99 for TFC. The mean absolute percent difference in parameters ranged from 2.0% for TFC to 11.0% for SVRI. For example, the mean absolute difference between MAP at 5 min and 10 min for the patients tested was 5.7 mm Hg, reflecting a 5.8% mean absolute percent difference between the 5-and 10-min measurements. The mean HR, SI, CI, and VI had small but statistically significant decreases in their 10-min values as compared with their 5-min values (all P Ͻ .01). The MAP also decreased (P Ͻ .05). The 10-min SVRI was greater than the 5-min SVRI; however, the difference was 
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not statistically significant (P ϭ .14). The TFC and STR were unchanged, with statistically insignificant differences (P ϭ 0.55 and 0.52, respectively).
Inter-Day Reproducibility
The reproducibility of the week 2 values compared with week 1 values is summarized in Tables 3 and 4 and plotted in Figs. 10 -17. The mean difference in time of day between the day 1 and day 2 monitoring sessions was 35 min (95% CI, 12 to 59 min). All parameters exhibited a strong correlation, although they were not as high as the intra-day measurements. The STR and MAP had the lowest correlations (0.66 and 0.67, respectively). An outlier significantly affected the STR correlation; removing the outlier resulted in a correlation of 0.80. Correlation for the remaining ICG parameters ranged from 0.78 for TFC to 0.88 for VI. The mean absolute percent change was also greater as compared with the intra-day. The changes ranged from 6.6% for HR to 18.1% for SVRI.
Discussion
The results obtained in this study indicate that in CAD patients, current ICG technology has high intra-day and inter-day reproducibility. Inter-day reproducibility measured by correlation, absolute difference, and absolute percent difference was expectedly greater than intra-day reproducibility. In addition, ICG is responsive to intra-day hemodynamic changes that occur during an initial period of rest. Although changes in 10-min v 5-min values for MAP, HR, SI, CI, and VI were statistically significant, they were not clinically significant. Because there was no gold standard for accuracy used in this study, we cannot determine the exact source of differences between measurements; however, we believe that the differences in the 10-min v the 5-min values can be attributed largely to normal physiologic response to rest that has been shown previously in HR and BP. 11 Other factors that could affect the intra-day reproducibility include operator technique and patient motion.
The parameter with the lowest intra-day variability (that is, the highest correlation and lowest mean absolute percent change) was TFC (2.0%). We suspect that this is due to physiologic factors. The TFC measurement is taken directly from the baseline impedance measured in the chest, which changes only when the net electrical conductivity of the chest changes. The net electrical conductivity of the chest changes due to increases or decreases in intravascular and extravascular fluid, which would not be expected to change within a 10-min period on the same Table 2 . Intra-day mean absolute and absolute percent differences between measurements (n ϭ 96) Abbreviations as in Table 1 . CI ϭ cardiac index, 95% CI ϭ 95% confidence interval, HR ϭ heart rate, MAP ϭ mean arterial pressure, SD ϭ standard deviation, SI ϭ stroke index, STR ϭ systolic time ratio, SVRI ϭ systemic vascular resistance index, TFC ϭ thoracic fluid content, VI ϭ velocity index.
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day. The parameter with the highest intra-day variability was SVRI (11%). The variation in SVRI can be attributed to the combined, known variability of the individual components of SVRI, which include HR, CI, and MAP. There were no statistically significant differences in the inter-day mean values for any of the hemodynamic parameters in the CAD population. Other than STR (r ϭ 0.66) and MAP (r ϭ 0.67), the correlation between day 2 and day 1 measurements remained high (r ϭ 0.79 to 0.88). There was an expectedly greater mean absolute percent difference in the hemodynamic values for the inter-day as compared with the intra-day results. The inter-day differences are likely due to the same reasons as intra-day variation but are of greater magnitude because of the expectedly greater hemodynamic changes taking place over a 1-week period. It may be possible to generalize our findings to other populations with cardiovascular disease, as our results are consistent with a similar ICG reproducibility study in heart failure patients in whom there was higher variability for inter-day measurements than for intra-day comparisons. 12 In caring for patients with cardiovascular disease, physicians are called upon to interpret serial hemodynamic measurements obtained by ICG in their patients. To apply the results of this study to patient management decisions, clinicians might consider changes that fall outside of the demonstrated ranges to reflect changes in disease status or as intended or unintended effects of therapeutic interventions. Likewise, the lack of change outside the demonstrated ranges may indicate the underlying hemodynamic status due to disease or intervention has not changed. Of course, changes in ICG parameters alone cannot be used in isolation; they are just one aspect of patient evaluation and should always be used in concert with history, physical examination, and other diagnostic and laboratory tests.
There are several limitations to this study. All of the potential factors that contribute to changes in hemodynamic values (such as when the patient had last eaten) were not collected and thus were not factored into the results. In addition, although changes in mean values were used to estimate physiologic changes, it is not possible to completely separate variability due to factors intrinsic to ICG technology from variation in physiologic state that is likely present in patients with underlying cardiovascular disease. The study design and relatively short interval between inter-day measurements makes variation due to disease progression or response to therapeutic intervention unlikely. Finally, because the study was based on only one group of CAD patients at a single site, the week-to-week variation in hemodynamic values may not be applicable to other patient populations.
In conclusion, managing disease progression and effi- Abbreviations as in Table 1 . Table 4 . Inter-day mean absolute and absolute percent differences between measurements (n ϭ 71)
Parameter
Inter-day mean absolute difference ؎ SD (95% CI)
Inter-day mean absolute % difference ؎ SD (95% CI) cacy of therapeutic intervention in the outpatient setting relies heavily on patient symptoms and physician examination. However, underlying hemodynamic changes may occur before any changes in symptoms or physical findings. Since most of the therapeutic agents used in treating the CAD patient have hemodynamic effects, accurate and reproducible noninvasive hemodynamic information can aid the clinician in evaluating the efficacy of treatment or the occurrence of disease progression or both. The relatively high degree of intra-and inter-day reproducibility demonstrated in this study suggests that serial ICG measurements provide clinically useful information with which to assess changes in patient status.
